1 The occurrence of IGF-I was investigated in rabbits with experimentally daunorubicin-induced cardiomyopathy. IGF-I was measured in the heart, serum, liver and skeletal muscle.
2 A significant increase in the IGF-I was found in the left heart ventricle in daunorubicin cardiomyopathy (152.9±10.0 ng/g vs 95.1±4.2 ng/g in the control group). This site of increased IGF-I activity corresponded well with the maximum of morphological changes (dispersed cytolysis of cardiomyocytes mostly without developed subsequent interstitial myofibrosis).
3 The highest levels of IGF-I were present in right and left cardiac atrium (but without significant differences between the groups). Furthermore, in skeletal muscle, the levels of IGF-I in the daunorubicin group (839.0±142.1 ng/g) were significantly higher in comparison with the control group (482.5±83.1 ng/g).
4 The level of IGF-I in the left ventricle in the daunorubicin group (but not in the control group) was significantly higher than that in the liver. There were no correlations observed between the levels of IGF-I in the heart and in the serum.
5 The increase in IGF-I concentrations in the left heart ventricle after the administration of daunorubicin may thus reflect possible autocrine/paracrine role of IGF-I in cardiomyopathy.
Loughna PT , Mason P , Bates PC.Regulation of insulin-like growth factor I gene expression in skeletal muscle . Symposia of the Society for Experimental Biology1992; 46: 319-330 .
2.
Kupfer JM , Rubin SA.Differential regulation on insulin-like growth factor I by growth hormone and thyroid hormone in the heart of juvenile hypophysectomised rats . J Molec Cell Cardiol1992; 24: 631-639 .
3.
Guse AHet al.Identification and characterisation of insulin-like growth factor receptors on adult rat cardiac myocytes: linkage to inositol 1,4,5- triphosphate formation . Endocrinology1992; 130: 145-151 .
4.
Duerr RLet al.Cardiovascular effects of insulin-like growth factor-1 and growth hormone in chronic left ventricular failure in the rat . Circulation1996; 93: 2188-2196 .
5.
Cittadini Aet al.Growth hormone attenuates early left ventricular remodelling and improves cardiac function in rats with large myocardial infarction . J Am Coll Cardiol1997; 29: 1109-1116 .
6.
Ambler GRet al.Improvement of doxorubicin induced cardiomyopathy in rats treated with insuline-like growth factor I . Cardiovasc Res1993; 27: 1368-1373 .
7.
Geršl V , Hrdina R.Non-invasive polygraphic cardiac changes in daunorubicin-induced cardiomyopathy in rabbits . Sborník vědeckych Prací LF UK Hradec Králové1994; 37: 49-55 .
8.
Geršl Vet al.Lack of cardiotoxicity of a new antineoplastic agent, a synthetic derivate of indenoisochinoline: comparison with daunorubicin in rabbits . Arch Toxicol1996; 70: 645-651 .
9.
Czarnecki CM.Animal models of drug-induced cardiomyopathy . Comparative Biochemistry and Physiology1984; 79: 9-14 .
10.
D'Ercole AJ , Stiles AD , Underwood LE.Tissue concentrations of somatomedin C: Further evidence for multiple sites of synthesis and paracrine or autocrine mechanisms of action . Proc Natl Acad Sci USA1984; 81: 935-939 .
11.
Flyvbjerg A , Jùrgensen KD , Marshall SM , érskov H.Inhibitory effect of octreotide on growth hormone-induced IGF-I generation and organ growth in hypophysectomized rats . Am J Physiol1991; 260: E568-E574 .
12.
Daughaday WA , Mariz IK , Blethen SL.Inhibition of access of bound somatomedin to membrane receptor and immunobinding sites: a comparison of radioreceptor and radioimmunoassay of somatomedin in native and acid-ethanol-extracted serum . J Clin Endocrin Metab1980; 51: 781-788 .
13.
Weissler AM , Schoenfeld CD.Effect of digitalis on systolic time intervals in heart failure . Am J Med Sci1970; 259: 4-20 .
14.
Woolf N.Ischemia and infarction. In: McGee, JOD , Isaacson, PG , Wright NA. (eds.) Oxford textbook of pathology, vol. 1. Oxford New York Tokyo, Oxford University Press , 1992.
15.
Acker SABE vanet al.Doxorubicin-induced chronic cardiotoxicity measured in freely moving mice. In: Reduction of Anticancer Drug Toxicity. Zeller WJ , Eisenbrand G , Hellman K (eds), vol. 48. Basel: Karger1995.
16.
Sinha BK.Cardiovascular Toxicology. Van Stee EW (ed.), New York: Raven Press1982.
17.
Reeves WC , Griffith JW , Wood MA , Whitesell L.Exacerbation of doxorubicin cardiotoxicity by digoxin administration in an experimental rabbit model . IntJCancer1990; 45: 731-736 .
18.
Geršl Vet al.Changes in cholinesterase activities after daunorubicin administration to rabbits . Hum Exp Toxicol1996; 15: 834-838 .
19.
Cini Neri Get al.Anthracycline cardiotoxicity: in vivo and in vitro effects on biochemical parameters and heart ultrastructure of the rat . Oncology1991; 48: 327-333 .
20.
Freestone NS , Ribaric S , Mason WT.The effect of insulin-like growth factor-1 on adult rat cardiac contractility . MolCellBiochem1996; 163-164: 223-229 .
21.
Ruskoaho Het al.Mechanisms of mechanical load-induced atrial natriuretic peptide secretion: role of endothelin, nitric oxide, and angiotensin II . J Molec Med1997; 75: 876-885 .
22.
Geršl V , Goiny M , Uvnäs-Wallensten K.The occurrence of Gastrin-17 in the heart . Acta Physiologica Scandinavica1981; 111: 307-310 .
23.
Cheng Wet al.Down-regulation of the IGF-I system parallels the attenuation in the proliferative capacity of rat ventricular myocytes during postnatal development . Laboratory Investigation1995; 72: 646-655 .
24.
Kluge ARet al.Insulin-like growth factor I is involved in inflammation linked angiogenic processes after microembolisation in porcine heart . Cardiovasc Res1995; 29: 407-415 .
25.
Decker RS , Cook MG , Behnke-Barclay M , Decker ML.Some growth factors stimulate cultured adult rabbit ventricular myocyte hypertrophy in the absence of mechanical loading . Circ Res1995; 77: 544-555 .
26.
Cheng Wet al.Aging does not affect the activation of the myocyte insulin-like growth factor-1 autocrine system after infarction and ventricular failure in Fischer 344 rats . Circ Res1996; 78: 536-546 .
27.
Florini JR , Ewton DZ.Actions of anabolic hormones and growth factors on cultured neonatal heart cells . Growth Regulation1995; 5: 28-35 .
28.
Kluge Aet al.Coordinate expression of the insulin-like growth factor system after microembolisation in porcine heart . Cardiovasc Res1997; 33: 324-331 .
29.
Buerke Met al.Cardioprotective effect of insulin-like growth factor I in myocardial ischemia followed by reperfusion . Proc Natl Acad Sciences USA1995; 92: 8031-8035 .
30.
Ross Jr J , Hongo M.The role of hypertrophy and growth factors in heart failure . Journal of Cardiac Failure1996; 2Suppl: S121-S128 .
31.
Donath MYet al.Cardiovascular and metabolic effects of insulin-like growth factor I at rest and during exercise in humans . J Clin Endocrinol Metab1996; 81: 4089-4094 .
32.
Gomberg-Maitland M , Frishman WH.Recombinant growth hormone: a new cardiovascular drug therapy . Am Heart J1996; 132: 1244-1262 .
33.
Lombardi Get al.Cardiovascular aspects in acromegaly: effects of treatment . Metabolism1996; 45: Suppl 1: 57-60 .
34.
Barton JS , Hindmarsh PC , Preece MA.Serum insulin-like growth factor 1 in congenital heart disease . Archives of Disease in Childhood1996; 75: 162-163 .
35.
Reiss Ket al.Fibroblast proliferation during myocardial development in rats is regulated by IGF-I receptors . Am J Physiol1995; 269: H943-H951 .
36.
Butt RP , Laurent GJ , Bishop JE.Collagen production and replication by cardiac fibroblasts is enhanced in response to diverse classes of growth factors . Eur J Cell Biol1995; 68: 330-335 .
37.
Fanciulli Met al.The interacting RNA polymerase II subunits, hRPB11 and hRPB3, are coordinately expressed in adult human tissues and down-regulated by doxorubicin . FEBS Lett1998; 427: 236-240 .
38.
Jennische E.Sequential immunohistochemical expression of IGF-I and the transferrin receptor in regenerating rat muscle in vivo . Acta Endocrin (Copenh)1989; 121: 733-738 .
39.
Yang H , Alnaqeeb M , Simpson H , Goldspink G.Changes in muscle fibre type, muscle mass and IGF-I gene expression in rabbit skeletal muscle subjected to stretch . JAnat1997; 190: 613-622 .
40.
Friberg Pet al.Cardiac hypertrophy and related growth processes: the role of insulin-like growth factor-I . Blood Pressure Supplement1995; 2: 22-29 .
